Obinna Ubah

Company: Elasmogen Ltd

Job title: Principal Scientist

Seminars:

2:30pm Development and functional characterization of ELN28, a Novel soloMER Drug Conjugate (SDC) targeting TNFα and JAK enzymes in Immune Mediated Inflammatory Diseases 2:30 pm

Elasmogen has designed a first-in-class soloMER drug conjugate tailor-made for autoimmune and inflammatory diseases. This innovative treatment utilizes a super-potent, novel-acting multivalent anti-TNFα soloMER to site-deliver an antiinflammatory JAK inhibitor payload, Tofacitinib. We will be presenting in vivo, ex vivo efficacy, PK and Biodistribution data.Read more

day: Day Two Discovery Track